Masks Deemed Safe for Asthma Patients
Oxygen saturation levels similar for both asthma patients and non-asthma patients following mask use.
Sublingual Immunotherapy May Provide Peanut Allergy Desensitization in Toddlers
Late-breaking data show allegic children as young as 1-4 years old may have sustained benefit from daily peanut protein exposure.
Study: Pediatric Adherence to Drugs Treating Severe Asthma is About 57%
An interview with a Children's Hospital Colorado investigator on new remote-monitoring research into children's adherence trends.
Early Phase Trial Results Positive for HCQ Against COVID-19
Trials testing hydroxychloroquine against COVID-19 have produced mixed results.
Early Peanut Introduction Decreases Rates of Peanut Allergies
The adjusted allergy prevalence in recent years was 2.6% in infants who have been introduced to peanuts at 12 months.
Breathing Difficulty Still Common in Hospitalized COVID-19 Patients After 6 Months
New survey results depict unexpected burdens in long-haul patients, as well as continued issues following rehabilitation.
Asthma Users Weight Positives, Negatives for Cannabis Use
Common positive effects includes help with sleep, less pain, and calming influence.
PONENTE: Benralizumab Reduces Oral Corticosteroid Use in Severe Asthmatics
An interview with a study author on new interpretations of biologic asthma benefit.
PALFORZIA at 3 Years: New Data Show Sustained Peanut Immunotherapy Benefit, Safety
A discussion on continued research into the first regulated treatment for pediatric peanut allergy.
Dupilumab Gets Results Treating Pediatric Atopic Dermatitis
Treatment showed a similar effect on patients with and without baseline asthma.
MMR Vaccine Shows Some COVID-19 Protection
All patients in the study who tested positive for COVID-19 suffered from mild or moderate symptoms.
Dupilumab Shows Promise in Phase 3 Trials Against CRSwNP
Researchers explore further endpoints from the SINUS-24 and SINUS-52 trials.
Dupilumab Helps Treat Uncontrolled Asthma
In data presented at AAAAI 2021, researchers present new data from the LIBERTY ASTHMA QUEST trial.
Dupilumab Reduces Doses of Oral Corticosteroids for Asthma Patients
Allergic rhinitis is the most frequent atopic coexisting disease in the LIBERTY ASTHMA VENTURE study.
Mobile Asthma Application Improves Patient Knowledge
A pediatric version of the ASTHMAXcel mobile application will include games.
Follow-Up Viaskin Peanut Patch Data Shows Cross-Contamination Benefit
The three-year study represents the largest long-term kinetic immunotherapy trial.
Avapritinib Shows Promise in Systematic Mastocytosis Trial
In the phase 2 PIONEER trial, patients taking avapritinib self-reported improvements in quality of life.
Dennis Ledford, MD: The Importance of Recognizing Anaphylaxis
As medical knowledge continues to grow, Dennis Ledford. MD, explains the importance of doctors in different fields collaborating.
Reaching a Future of Optimized Food Allergy Therapies
The first generation of food allergy treatments is nearing the market. What could be next is more individualized therapies.
Improving Food Allergy Testing & Collaboration
What other specialties should become more involved in the network of care for allergic patients?
Hugh Windom, MD: Understanding Food Allergy Rates
Is the US population having allergies diagnosed correctly, and are allergies on the rise?
Addressing Adult Patients, Comorbidities in Food Allergies
Pediatric peanut allergy trials have proven successful. Now where do researchers look next?
Dupilumab Improves Outcomes in SINUS-52
In this phase 3 study, dupilumab improved outcomes for patients with recurring severe chronic rhinosinusitis with nasal polyps.
Hugh Windom, MD: Treating Food Allergy with Allergen Exposure
What does the typical patient have to treat aside from their allergy, and what are their treatment goals?
Eating Peanut After Immunotherapy Linked to Positive Outcomes
Patients who incorporated small amounts of peanut into their diet experienced increased quality of life.
Brian Vickery, MD: Food Allergy Guidelines' Role in New Therapies
Have current guidelines been fitted to consider the future of immunotherapy research?
Can Food Challenges Help Individualize Allergy Therapy?
UNC investigators consider the role current food allergy trials may play in addressing gaps of knowledge on patient individualization.
Babies Who Reacted to Allergen Exposure Breastfed Longer
Mothers reported breastfeeding infants who reacted to food allergen exposure via breastmilk for significantly longer than infants who did not react.
Severe Eosinophilic Asthma Linked to Low FEV1 Reversibility
Investigators conducted a post-hoc analysis in order to assess eosinophil levels and lung function among patients with low FEV1 reversibility to short-acting beta agonists.
Brian Vickery, MD: Setting Dosing Standards for Immunotherapy Trials
Why it may be critical to reassess dosing practices being practiced in investigative food allergy therapies.